Germany-based Merck plans to use analytics and machine learning to predict and prevent drug shortages, a move that could also save it money.
A better supply-and-demand forecast also makes it easier for Merck to expand into locations without a reliable supply-chain infrastructure, such as parts of Africa and Southeast Asia. A lot of growth from pharma companies is coming from emerging markets…and some of the logistics there are challenging.